Who Won It

Contract award · 4 Apr 2025

NP48925d Hereditary Angioedema Branded Medicines (Cinryze and Takhzyro)

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") awarded “Hereditary Angioedema…” to Takeda UK Ltd for £9.46m.

No competitionMedical equipment & pharmaceuticalsScotland

BuyerThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Value £9.46m
WinnerTakeda UK Ltd

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") · Body governed by public law
Supplier
Takeda UK Ltd
Value
£9,461,556
Procedure
Award procedure without prior publication of a call for competition
Sector
Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
Region
Scotland
Official notice
018770-2025 on Find a Tender
Timeline
  1. Contract date4 Apr 2025
  2. Published2 May 2025Published 28 days after the contract date

Description

The Framework Agreement is for the supply of several hereditary angioedema (HAE) branded medicines to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.

About the supplier

Other awards in the same procurement

Call-offs and awards published under the same process (for example a framework or dynamic purchasing system).

Date Contract Supplier Value
4 Apr 2025
Takeda UK Ltd £9.46m

More from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

All contracts

More won by Takeda UK Ltd

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview